1
|
Sachetti CG, Júnior AB, de Carvalho ACC, Angulo-Tuesta A, da Silva EN. Landscape of Brazilian research and development public funding in advanced therapies: lessons learned and a roadmap for middle-income economies. Cytotherapy 2022; 24:1158-1165. [DOI: 10.1016/j.jcyt.2022.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Revised: 06/24/2022] [Accepted: 06/26/2022] [Indexed: 11/03/2022]
|
2
|
Framing regenerative medicine: culturally specific stories of an emerging technoscience. BIOSOCIETIES 2021. [DOI: 10.1057/s41292-021-00236-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
3
|
Matthews KRW, Moralí D. National human embryo and embryoid research policies: a survey of 22 top research-intensive countries. Regen Med 2020; 15:1905-1917. [DOI: 10.2217/rme-2019-0138] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
Research using human embryos and embryoids has expanded in recent years due to technological advances. Surveying laws and guidelines among the top research and development (R&D) investing nations highlights existing barriers to expanding this area of research. Of the 22 nations surveyed, we found 12 countries with a 14-day limit, one with a seven-day limit, five with prohibitions and four without national laws or guidelines that limit or prohibit human embryo research. Sixteen national laws or guidelines define an embryo or related entities, with five nations limiting human embryoid research. Other laws are ambiguous in relation to embryoid research, leave unanswered questions regarding what research is permitted or restricted and need additional clarity for researchers.
Collapse
Affiliation(s)
- Kirstin RW Matthews
- Baker Institute Center for Health & Biosciences; Rice University; Houston, TX 77005, USA
| | - Daniel Moralí
- Baker Institute Center for Health & Biosciences; Rice University; Houston, TX 77005, USA
| |
Collapse
|
4
|
Gopalan N, Nor SNM, Mohamed MS. Global Human Embryonic Stem Cell Laws and Policies and Their Influence on Stem Cell Tourism. Biotechnol Law Rep 2018. [DOI: 10.1089/blr.2018.29088.ng] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
5
|
Chan S, Medina Arellano M. Genome editing and international regulatory challenges: Lessons from Mexico. ACTA ACUST UNITED AC 2016. [DOI: 10.1016/j.jemep.2016.05.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|